Manufacturer record

Smayan Healthcare Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

8 batches manufactured by Smayan Healthcare Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2022 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

8 records linked to Smayan Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
8Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2022 to Jun 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

8
NSQ batches since 2022
7
Products affected
Assay
Most common failure
Jun 2026
Latest alert

Flagged batches per year

2022 · 12023 · 32026 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Paracetamol Paediatric Oral Suspension IP L5G174Mfg 2025-07 · Exp 2027-06 Test For Assay (Content) Of ParacetamolAssay DelhiState lab Jun 2026
Paracetamol Paediatric Oral Suspension IP L5G175Mfg 2025-07 · Exp 2027-06 Test For Assay (Content) Of ParacetamolAssay DelhiState lab Jun 2026
Adenosine Injection IP 6 mg/2ml I5K048Mfg 2025-11 · Exp 2027-10 The sample does not conforms to I.P. 2022 with respect to the test for pHpH CDTL, MumbaiCDSCO lab Jun 2026
Paracetamol Pediatric Oral Suspension IP L4H088Mfg 2024-08 · Exp 2026-07 Assay for paracetamol does not comply as per IP 2022.Assay DCL, TelanganaState lab Jan 2026
Ofloxacin, Ornidazole, Itraconazole & Clobetasol Propionate Cream (Derma-RX Cream) E3H021Mfg 2023-08 · Exp 2025-07 Assay of Clobetasol PropionateAssay CDL KolkataCDSCO lab Oct 2023
Ambroxol HCl, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup (Toscof- TR) L3H148Mfg 2023-08 · Exp 2025-07 Assay of MentholAssay CDL KolkataCDSCO lab Oct 2023
Aceclofenac & Paracetamol Oral Suspension (SIGAFENAC-P) L3C152Mfg 2023-03 · Exp 2025-02 Assay of Aceclofenac & ParacetamolAssay CDL KolkataCDSCO lab Oct 2023
Lignocaine Hydrochloride Gel IP (LIGNOMARK JELLY) E1C060Mfg 2021-03 · Exp 2023-02 AssayAssay RDTL ChandigarhCDSCO lab Mar 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.